N/A
N=68
Piloting 'mPal,' a Multilevel Strategy for Palliative Care Implementation
Lung Cancer
Bottom Line
View on ClinicalTrials.gov: NCT05270395 ↗Enrolled (actual)
68
Serious AEs
0.0%
Results posted
May 2025
Primary outcome: Primary: Feasibility of Enrollment — 75 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- mPal (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Laurie McLouth
- Primary completion
- Mar 2024
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Feasibility of Enrollment |
75 | — |
| SECONDARY Patient Palliative Care Referrals |
2; 2 | — |
| SECONDARY Acceptability of Intervention |
3.95 | — |
| SECONDARY Change in Palliative Care Attitudes |
1.12; -0.07 | — |
| SECONDARY Feasibility of Intervention |
4.03 | — |
| SECONDARY Feasibility of Retention |
30; 30 | — |
| SECONDARY Change in Palliative Care Knowledge - Health Information National Trends Survey Palliative Care Knowledge and Perceptions Questionnaire (HINTS), Item 1: How Would You Describe Your Level of Knowledge About Palliative Care? |
35.71; 14.29 | 0.02 sig |
| SECONDARY Change in Palliative Care Knowledge - Health Information National Trends Survey Palliative Care Knowledge and Perceptions Questionnaire (HINTS), Item 2: Help Friends and Family to Cope With a Patient's Illness |
76.67; 70.37 | 0.63 |
| SECONDARY Change in Palliative Care Knowledge - Health Information National Trends Survey Palliative Care Knowledge and Perceptions Questionnaire (HINTS), Item 3: Offer Social and Emotional Support |
73.33; 88.46 | 0.13 |
| SECONDARY Change in Palliative Care Knowledge - Health Information National Trends Survey Palliative Care Knowledge and Perceptions Questionnaire (HINTS), Item 4: Manage Pain and Other Physical Symptoms |
76.67; 84.62 | 0.40 |
| SECONDARY Change in Palliative Care Knowledge - Health Information National Trends Survey Palliative Care Knowledge and Perceptions Questionnaire (HINTS), Item 5: Give Patients More Time at the End of Life |
26.67; 15.38 | 0.29 |
| SECONDARY Change in Palliative Care Knowledge - Health Information National Trends Survey Palliative Care Knowledge and Perceptions Questionnaire (HINTS), Item 6: Accepting Palliative Care Means Giving up |
80.00; 62.96 | 0.07 |
| SECONDARY Change in Palliative Care Knowledge - Health Information National Trends Survey Palliative Care Knowledge and Perceptions Questionnaire (HINTS), Item 7: It is a Doctor's Obligation to Inform All Patients With Cancer About the Option of Palliative Care |
72.41; 67.86 | 0.09 |
| SECONDARY Change in Palliative Care Knowledge - Health Information National Trends Survey Palliative Care Knowledge and Perceptions Questionnaire (HINTS), Item 8: If You Accept Palliative Care, You Must Stop Other Treatments |
73.33; 62.96 | 0.42 |
| SECONDARY Change in Palliative Care Knowledge - Health Information National Trends Survey Palliative Care Knowledge and Perceptions Questionnaire (HINTS), Item 9: Palliative Care is the Same as Hospice Care |
66.67; 48.15 | 0.08 |
| SECONDARY Change in Palliative Care Knowledge - Health Information National Trends Survey Palliative Care Knowledge and Perceptions Questionnaire (HINTS), Item 10: When I Think of "Palliative Care," I Automatically Think of Death |
70.00; 34.62 | 0.004 sig |
Summary
The purpose of this study is to assess the feasibility and acceptability of mPal, a multilevel implementation strategy to improve palliative care use among advanced stage lung cancer patients receiving cancer treatment.
Eligibility Criteria
Inclusion Criteria
- new or recurrent AJCC stage IIIb-IV non-small cell lung cancer or extensive stage small cell lung cancer
- ECOG performance status 0-3/Karnofsky 40-100
- at least three weeks into active oncologic treatment (chemotherapy, immunotherapy, chemo-immunotherapy)
Exclusion Criteria
- unstable brain metastases
- Cognitive (i.e., dementia) or psychiatric condition (e.g., psychotic disorder) for which participating would be inappropriate
- Receiving palliative care
- Unable to speak and read English
Data sourced from ClinicalTrials.gov (NCT05270395). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.